Datasets:
tahasawan
/
Health_Dataset

Dataset card Data Studio Files
xet
 Community
2
Country
stringclasses
20 values
Year
int64
2k
2.02k
Disease Name
stringclasses
20 values
Disease Category
stringclasses
11 values
Prevalence Rate (%)
float64
0.1
20
Incidence Rate (%)
float64
0.1
15
Mortality Rate (%)
float64
0.1
10
Age Group
stringclasses
4 values
Gender
stringclasses
3 values
Population Affected
int64
1k
1,000k
Healthcare Access (%)
float64
50
100
Doctors per 1000
float64
0.5
5
Hospital Beds per 1000
float64
0.5
10
Treatment Type
stringclasses
4 values
Average Treatment Cost (USD)
int64
100
50k
Availability of Vaccines/Treatment
stringclasses
2 values
Recovery Rate (%)
float64
50
99
DALYs
int64
1
5k
Improvement in 5 Years (%)
float64
0
10
Per Capita Income (USD)
int64
502
100k
Education Index
float64
0.4
0.9
Urbanization Rate (%)
float64
20
90
Russia
2,009
Dengue
Genetic
3.82
5.91
6.13
36-60
Female
991,599
93.08
0.62
8.2
Therapy
21,106
No
56.65
1,023
9.05
97,493
0.63
76.31
Russia
2,011
Dengue
Neurological
1.33
1.18
0.52
36-60
Male
241,942
93.66
3.25
7.51
Medication
44,683
No
74.1
3,066
1.82
11,156
0.61
71.14
Italy
2,021
Alzheimer's Disease
Bacterial
15.42
13.7
6.65
0-18
Other
322,062
87.91
4.63
5.53
Vaccination
2,323
No
96.96
974
0.98
19,666
0.42
80.55
Germany
2,007
Tuberculosis
Infectious
18.68
4.82
2.46
19-35
Male
882,446
87.79
2.19
7.8
Therapy
19,849
No
54.24
3,762
2.3
40,785
0.76
47.34
Brazil
2,007
Hypertension
Parasitic
10.46
14.96
1.87
19-35
Female
252,914
72.92
4.98
5.34
Vaccination
48,724
No
65.24
3,945
3.82
37,833
0.51
30.68
Nigeria
2,004
Rabies
Respiratory
4.86
2.72
9.34
36-60
Other
507,614
50.51
1.42
2.1
Medication
15,563
No
52.76
4,505
4.99
44,130
0.52
61.05
Indonesia
2,024
Parkinson's Disease
Bacterial
3.25
11.43
5.69
36-60
Female
938,134
62.27
2.21
7.15
Surgery
11,287
No
79.92
1,666
6.19
19,390
0.55
57.63
Russia
2,012
Cancer
Viral
11.46
13.96
0.32
61+
Male
3,062
98.41
1.15
2.29
Therapy
1,713
Yes
69.84
4,045
3.51
88,910
0.41
60.81
South Korea
2,011
Cancer
Respiratory
11.26
8.88
3.97
0-18
Male
634,981
91.16
2.57
3.2
Therapy
8,014
No
58.44
4,669
3.76
90,693
0.57
78.26
Mexico
2,009
Hepatitis
Genetic
14.24
0.87
0.4
61+
Female
994,017
54.9
3.44
1.35
Therapy
25,682
No
54.34
988
3.11
22,745
0.49
71.14
South Africa
2,001
Diabetes
Chronic
14.3
13.71
2.03
19-35
Male
699,578
69.12
1.8
1.77
Therapy
1,601
No
78.96
2,571
5.27
90,761
0.78
59.06
Argentina
2,004
Hypertension
Neurological
2.47
11.18
1.36
36-60
Female
47,600
64.69
2.95
3.24
Therapy
29,676
No
50.11
2,780
6.08
52,760
0.69
34.47
South Africa
2,003
Parkinson's Disease
Parasitic
10.76
3.83
2.15
19-35
Female
395,804
93.2
2
9.69
Vaccination
17,781
Yes
97.23
1,772
3.97
59,041
0.7
80.72
Japan
2,013
Diabetes
Autoimmune
2.33
7.71
5.91
19-35
Other
502,051
67.23
1.24
1.76
Therapy
25,684
No
97.47
2,090
5.75
31,715
0.62
22.82
Brazil
2,018
Ebola
Cardiovascular
4.43
4.98
3.61
61+
Female
983,107
80.5
4.74
4.13
Medication
21,201
Yes
81.41
2,381
9.64
40,643
0.69
50.42
Saudi Arabia
2,021
Rabies
Metabolic
9.16
3.33
0.69
0-18
Female
922,485
66.31
4.04
4.64
Therapy
20,394
Yes
77.17
2,572
3.13
26,387
0.47
40.57
USA
2,020
Cholera
Metabolic
1.79
6.89
6.44
19-35
Female
804,321
75.87
2.88
4.41
Vaccination
49,936
No
55.23
4,819
9.8
35,748
0.83
38.94
South Africa
2,002
Ebola
Bacterial
12.54
10.98
5.78
61+
Male
701,376
61.71
2.88
3
Medication
36,242
Yes
94.79
390
1.05
28,321
0.86
69.45
Germany
2,003
Diabetes
Parasitic
16.37
9.52
5.02
19-35
Male
434,862
72.61
2.05
6.07
Medication
14,388
Yes
63.81
4,532
3.28
60,269
0.54
23.84
Indonesia
2,008
Hepatitis
Metabolic
6.56
9.01
9.77
61+
Female
39,391
51.9
1.09
4.65
Surgery
23,946
Yes
88.45
4,871
1.79
29,920
0.84
25.91
South Korea
2,003
Rabies
Infectious
13.55
2.97
7.24
0-18
Female
511,324
91.57
1.59
2.02
Surgery
41,910
Yes
93.6
1,838
4.42
28,572
0.68
65.96
Nigeria
2,016
Polio
Viral
14.8
7.17
9.15
19-35
Female
196,004
99.57
1.12
9.87
Therapy
34,962
Yes
98.95
4,816
2.74
82,456
0.41
54.15
Italy
2,023
Cancer
Genetic
5.83
12.81
5.14
0-18
Female
124,710
85.81
3.09
7.69
Therapy
31,135
No
83.75
526
2.41
78,055
0.74
20.84
Argentina
2,000
Influenza
Autoimmune
19.42
10.09
5.62
0-18
Other
215,789
61.25
1.13
4.77
Therapy
24,943
No
73.44
4,683
2.08
27,129
0.89
46.02
Saudi Arabia
2,018
Parkinson's Disease
Respiratory
19.61
0.72
2.37
0-18
Male
809,469
98.63
0.97
9
Therapy
15,422
No
79.1
2,240
1.4
31,263
0.66
86.95
India
2,005
Parkinson's Disease
Viral
11.67
1.93
3.11
61+
Other
996,897
66.03
4.71
3.73
Therapy
23,340
No
68.61
1,329
4.84
55,850
0.47
20.32
China
2,012
Malaria
Genetic
7
13.32
5.71
61+
Female
532,759
93.8
4.2
5.03
Surgery
17,360
Yes
68.89
4,481
7.88
12,471
0.51
29.95
South Korea
2,020
COVID-19
Chronic
0.63
10.51
0.87
61+
Female
425,518
88.83
4.97
2.44
Therapy
19,807
Yes
60.1
1,273
8.31
88,721
0.54
36.46
Canada
2,018
Malaria
Chronic
16.42
3.41
7.48
36-60
Female
955,473
53.11
0.75
8.38
Therapy
37,492
No
51.76
863
4.72
97,769
0.79
41.66
Argentina
2,001
Hepatitis
Chronic
7.29
12.24
9.06
36-60
Other
454,403
52.94
4.61
8.64
Therapy
40,857
Yes
95.45
4,306
7.66
72,634
0.58
84.56
Nigeria
2,013
HIV/AIDS
Neurological
19.32
13.5
0.95
61+
Female
920,304
56.47
2.53
9.25
Surgery
22,921
Yes
57.05
4,551
6.95
95,227
0.69
88.93
Russia
2,004
Influenza
Parasitic
16.45
14.12
9.94
0-18
Other
617,098
66.42
4.5
3.14
Vaccination
16,448
No
50.51
2,098
4.72
7,469
0.55
82.39
Nigeria
2,017
Influenza
Bacterial
12.6
7.49
0.96
36-60
Male
34,605
64.13
3.02
7.35
Surgery
9,459
No
78.11
2,419
3.11
41,049
0.73
61.69
USA
2,009
Tuberculosis
Genetic
3.55
5.72
7.65
0-18
Male
641,109
51.35
3.57
3.69
Medication
6,566
No
88.18
4,298
0.39
3,170
0.9
43.77
Brazil
2,002
Influenza
Genetic
6.51
10.93
3.46
0-18
Female
202,916
92.32
0.77
8.9
Vaccination
40,197
Yes
74.01
4,735
4.06
60,016
0.45
84.74
France
2,001
Dengue
Chronic
1.4
4.26
1.63
0-18
Female
624,943
87.79
3.32
9.31
Vaccination
8,812
No
95.66
316
0.35
3,480
0.52
53.88
Brazil
2,010
Cholera
Metabolic
6.41
11.32
0.99
61+
Female
998,728
87.33
1.61
8.55
Vaccination
42,621
Yes
74.38
2,444
9.97
14,627
0.42
26.62
Canada
2,004
Cholera
Cardiovascular
7.15
5.48
9.83
19-35
Female
624,680
51.79
3.48
1.78
Therapy
47,925
Yes
89.98
2,581
7.26
66,019
0.86
88.23
China
2,020
Alzheimer's Disease
Viral
2.94
10.78
4.42
0-18
Male
434,445
93.03
1.52
3.83
Vaccination
14,592
Yes
76.11
3,700
9.22
27,910
0.54
39.78
Brazil
2,017
Tuberculosis
Bacterial
7.17
4.44
1.22
19-35
Other
232,007
61.97
3.44
8.77
Surgery
9,964
Yes
54.53
568
9.59
52,816
0.69
56.69
USA
2,000
Polio
Metabolic
7.11
6.3
9.61
19-35
Other
307,942
92.51
1.36
4.1
Surgery
31,355
No
53.71
4,010
2.38
41,287
0.86
62.77
Russia
2,005
Ebola
Genetic
12.47
9.57
0.95
36-60
Male
8,950
95.35
3.79
6.12
Medication
32,936
Yes
77.42
518
4.82
91,783
0.68
34.14
China
2,020
Alzheimer's Disease
Metabolic
7.18
1.17
1.31
0-18
Male
66,209
53.42
3.85
4.9
Medication
21,755
No
89.87
2,715
8.35
29,295
0.41
32.37
South Africa
2,021
Parkinson's Disease
Genetic
3.02
2.83
5.52
0-18
Male
541,943
69.57
1.78
4.39
Therapy
11,794
Yes
82.42
4,468
2.26
82,604
0.7
55.97
Indonesia
2,015
Measles
Neurological
14.3
5.89
3.26
19-35
Male
882,494
53.38
0.76
3.62
Medication
4,704
No
82.57
947
7.39
77,083
0.87
48.31
Brazil
2,004
Polio
Parasitic
16.53
14.5
8.91
19-35
Other
861,609
88.6
0.51
8.9
Medication
15,826
Yes
98.38
2,680
5.48
3,938
0.53
47.3
Turkey
2,006
COVID-19
Cardiovascular
19.79
7.23
9.08
36-60
Female
470,008
94.92
4.96
6.8
Surgery
43,965
Yes
85.53
2,845
1.09
36,478
0.89
41.14
Mexico
2,011
Leprosy
Chronic
16.65
0.47
3.14
61+
Other
969,945
67.63
3.75
4.55
Surgery
36,633
Yes
97
4,451
5.48
94,309
0.51
84.12
Argentina
2,021
Ebola
Viral
9.45
11.5
5.27
0-18
Other
547,603
71.57
4.73
6.4
Medication
49,493
No
86.25
2,783
8.63
90,504
0.72
34.91
Saudi Arabia
2,022
Cancer
Viral
11.87
13.66
6.55
19-35
Male
312,950
67.76
3.14
5.19
Medication
2,505
Yes
84.2
151
4.02
11,923
0.82
68.48
Nigeria
2,004
Asthma
Bacterial
11.71
6.4
5.63
61+
Other
36,402
86.05
4.49
6.98
Vaccination
5,529
Yes
59.31
1,775
7.39
68,854
0.64
66.24
Russia
2,021
Dengue
Genetic
11.73
0.18
2.66
36-60
Male
85,382
50.81
2.52
1.89
Surgery
49,372
Yes
66.31
1,412
7.07
19,380
0.4
78.73
Japan
2,007
Tuberculosis
Genetic
1.23
1.92
1.28
0-18
Female
903,936
56.08
0.65
5.13
Therapy
26,833
No
51.72
799
2.99
86,743
0.64
81.79
Saudi Arabia
2,021
Hepatitis
Respiratory
16.17
8.91
4.58
61+
Female
948,481
81.87
1.33
0.74
Surgery
42,823
No
98.76
1,136
2.59
31,966
0.43
82
Mexico
2,019
Rabies
Metabolic
2.11
6
4.28
19-35
Female
169,115
64.29
4.27
6.69
Medication
46,650
No
89.74
2,800
6.49
58,401
0.51
62.01
France
2,014
Dengue
Genetic
4.37
10.36
1.63
19-35
Other
221,470
82.71
0.89
2.29
Therapy
43,088
No
91.43
153
4.61
20,938
0.59
43.01
USA
2,013
Influenza
Bacterial
13.26
9.48
5.63
36-60
Other
776,469
88.07
2.49
2.53
Medication
49,441
Yes
76.81
1,554
4.61
92,519
0.71
88.93
UK
2,015
Dengue
Bacterial
7.42
10.64
6.19
61+
Other
642,560
50.51
4.24
4.56
Therapy
36,131
Yes
61.01
4,846
4.8
53,927
0.52
25.49
UK
2,000
Zika
Neurological
10.98
1.33
5.07
36-60
Other
320,551
54.32
0.56
5.47
Medication
8,589
No
68.98
4,360
2.1
98,356
0.66
39.71
Russia
2,021
Influenza
Parasitic
0.24
0.29
6.53
61+
Female
921,260
97.06
3.54
2.32
Therapy
8,378
No
97
76
5.23
39,382
0.56
69.76
Indonesia
2,016
Dengue
Parasitic
8.64
10.33
6.66
0-18
Other
356,686
86.75
4.46
2.21
Surgery
39,721
No
97.14
4,139
4.88
70,630
0.82
52.7
Russia
2,023
Rabies
Infectious
3.32
5.61
9.22
61+
Male
749,645
84.09
2.94
3.18
Surgery
41,521
Yes
51.52
479
0.64
82,928
0.68
21.69
France
2,003
Hepatitis
Viral
15.02
5.33
2.28
19-35
Male
135,476
81.26
2.04
3.09
Vaccination
19,787
No
52.1
2,213
0.73
81,274
0.84
40.39
China
2,014
Tuberculosis
Parasitic
7.88
0.97
9.04
0-18
Other
386,848
82.38
0.67
1.86
Therapy
13,580
No
65.62
1,501
8.78
24,578
0.48
30.45
Canada
2,007
Cholera
Autoimmune
10.16
10.26
5.2
0-18
Female
979,011
87.46
1.88
1.17
Medication
45,015
No
68.34
2,109
2.15
1,258
0.47
29.33
Mexico
2,008
COVID-19
Metabolic
7.32
11.43
9.81
0-18
Male
540,945
86.8
4.98
6.12
Surgery
5,410
Yes
82.4
242
9.83
50,840
0.53
86.99
UK
2,011
Leprosy
Respiratory
15.32
3.9
5.99
0-18
Male
489,434
50.35
4.83
1.44
Medication
30,297
Yes
83.7
3,849
1.79
23,087
0.88
88.84
Germany
2,021
HIV/AIDS
Parasitic
1.08
8.36
6.87
61+
Other
555,142
85.3
1.9
8.01
Therapy
28,326
No
89.12
3,401
0.18
51,588
0.87
75.51
Canada
2,007
Diabetes
Neurological
19.43
12.51
6.25
36-60
Male
170,799
85.9
4.92
3.34
Surgery
23,036
Yes
76.33
113
2.15
45,132
0.79
84.37
Mexico
2,022
Zika
Metabolic
16.53
7
7.05
36-60
Other
721,347
57.58
3.24
6.27
Medication
49,314
Yes
60
3,882
9.17
46,320
0.61
59.51
India
2,001
Polio
Neurological
18.4
14.58
0.96
36-60
Other
925,118
92.31
4.02
3.36
Surgery
32,446
No
64
1,631
7.22
87,336
0.81
62.78
Brazil
2,024
Polio
Parasitic
1.02
0.24
7.13
0-18
Other
628,587
97.59
4.77
5.25
Therapy
19,208
No
91.11
488
4.75
9,776
0.53
60.05
Japan
2,001
Hepatitis
Parasitic
1.98
14.12
4.22
0-18
Male
720,213
88.25
3.24
3.98
Vaccination
6,000
No
83.72
4,904
6.51
66,184
0.71
84.01
Saudi Arabia
2,006
Parkinson's Disease
Metabolic
0.15
4.42
8.93
0-18
Male
655,055
52.47
3.27
2.18
Medication
9,233
Yes
52.06
4,334
8.72
30,810
0.83
34.74
Japan
2,022
Alzheimer's Disease
Cardiovascular
17.17
6.87
3.9
19-35
Male
826,557
65.22
0.8
4.68
Vaccination
46,984
Yes
57.52
4,006
6.33
33,944
0.85
40.1
South Korea
2,019
Leprosy
Autoimmune
3.47
13.25
7.3
19-35
Other
146,665
78.53
3.34
0.62
Therapy
15,036
No
60.69
783
8.01
88,195
0.65
89.33
Brazil
2,015
Measles
Chronic
17.43
9.2
8.86
61+
Other
293,863
92.93
1.13
7.8
Therapy
26,978
Yes
96.1
1,667
5.29
56,945
0.57
78.18
Turkey
2,004
Ebola
Metabolic
5.33
3.43
3.67
0-18
Male
134,166
96.31
1.29
2.5
Surgery
2,282
No
68.6
4,096
5.95
35,286
0.57
86.68
Italy
2,012
COVID-19
Cardiovascular
19.87
1.63
2.47
19-35
Other
739,651
96.43
3.34
4.82
Medication
44,551
Yes
84.45
4,970
9.57
43,455
0.53
43.39
Indonesia
2,008
Hepatitis
Neurological
14.88
6.31
0.22
36-60
Other
819,053
51.88
3.3
6.92
Medication
4,747
Yes
55.32
978
0.14
33,382
0.7
42.02
Australia
2,003
Ebola
Bacterial
1.96
9.44
4.63
19-35
Female
709,402
74.43
2.33
7.4
Vaccination
43,102
No
87.56
3,132
4.21
81,196
0.66
21.82
Australia
2,009
Malaria
Metabolic
17.56
7.96
2.58
19-35
Male
162,826
93.3
3.81
7.97
Surgery
37,812
Yes
85.33
1,919
4.57
93,722
0.86
40.92
Australia
2,009
Measles
Viral
2.18
14.82
1.26
61+
Female
808,173
74.3
3.35
3.35
Medication
49,310
Yes
73.96
2,258
2.8
81,125
0.5
74.72
Japan
2,014
Measles
Viral
13.87
11.05
3.19
36-60
Other
161,634
93.78
2.73
3.58
Therapy
6,980
No
64.28
3,491
3.32
45,059
0.71
32.07
Russia
2,008
Ebola
Chronic
5.63
0.76
4.02
0-18
Male
978,978
51.89
3.45
6.66
Medication
1,559
Yes
88.86
2,463
9.84
84,750
0.49
28.97
Japan
2,007
HIV/AIDS
Autoimmune
11.68
12.42
2.71
61+
Other
532,065
83.5
3.94
6.96
Vaccination
24,588
No
76.64
114
3.46
93,411
0.48
66.21
Mexico
2,014
Cancer
Metabolic
16.87
6.57
8.16
19-35
Other
59,421
92.85
3.75
3.33
Medication
40,432
Yes
59.24
22
7.19
88,929
0.75
33.42
Australia
2,015
HIV/AIDS
Infectious
3.46
5.98
7.23
19-35
Other
958,022
66.13
2.35
2.26
Medication
32,105
Yes
64.68
1,024
2.99
45,906
0.66
22.29
Canada
2,006
HIV/AIDS
Chronic
12.6
3.37
7.88
0-18
Female
840,372
94.38
0.82
4.76
Medication
47,664
Yes
76.01
1,165
5.67
5,849
0.82
57.49
Brazil
2,006
Ebola
Parasitic
7.76
13.43
8.15
36-60
Male
715,887
78.58
3.28
8.36
Medication
41,164
No
54.34
2,847
5.72
22,700
0.83
40.65
China
2,009
Leprosy
Neurological
18.58
11.13
3.4
61+
Female
543,861
86.07
3.04
9.1
Medication
14,671
Yes
86.21
4,807
8.45
91,607
0.67
81.46
Canada
2,004
Zika
Chronic
8.5
13.84
4.81
0-18
Female
933,501
80.65
2.12
9.21
Therapy
30,755
Yes
86.67
4,558
3.69
88,317
0.82
63.4
Italy
2,020
Dengue
Cardiovascular
17.95
2.64
6.13
19-35
Female
264,557
98.62
2.65
8.42
Vaccination
8,203
No
55.27
1,025
1.15
73,360
0.67
50.93
Russia
2,024
Malaria
Metabolic
0.21
10.34
1.96
0-18
Other
263,477
98.49
2.27
2.66
Surgery
14,088
No
52.76
1,705
3.13
43,233
0.61
75.08
Italy
2,019
HIV/AIDS
Parasitic
11.64
13.98
8.08
61+
Male
16,688
89.16
3.11
6.79
Surgery
21,699
No
58.4
3,413
0.98
30,250
0.51
26.62
South Africa
2,021
Cancer
Neurological
16.89
2.28
8.52
19-35
Male
761,302
50.41
1.98
2.06
Therapy
38,765
Yes
54.03
3,597
6.97
49,689
0.5
25.4
Germany
2,010
COVID-19
Chronic
0.32
5.83
2.61
61+
Male
601,459
80.56
3.48
1.61
Surgery
25,446
No
55.96
2,808
6.06
48,806
0.81
42.76
Australia
2,023
HIV/AIDS
Infectious
14.77
14.26
7.36
19-35
Male
457,592
53.44
4.08
7.45
Surgery
34,511
No
67.64
2,816
0.41
57,776
0.82
77.74
Indonesia
2,000
Alzheimer's Disease
Autoimmune
6.46
14.2
6.62
0-18
Other
140,944
90.68
2.16
1.07
Vaccination
28,745
No
74.59
445
3.68
41,555
0.43
54.22
Italy
2,000
Malaria
Parasitic
10.62
1.03
0.65
0-18
Male
289,468
99.04
0.55
8.24
Vaccination
14,646
Yes
75.55
2,624
1.36
982
0.56
50.53